Picture Berlin Partner Bionnale 2021 Digital Event 650x80px

News > All

Total search results: 8369 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 82 83 84  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
BioPhero ApS. (3/9/21). "Press Release: BioPhero Announces $17 Million Series A For Sustainable Pest Control". Copenhagen. 2021-03-09
Ventyx Biosciences, Inc.. (3/9/21). "Press Release: Ventyx Biosciences Raises $114 Million Financing Led by VenBio Partners to Advance Diverse Pipeline of Immunology Programs". Encinitas, CA. 2021-03-09
Mikrogen GmbH. (3/8/21). "Press Release: Mikrogen Acquires Lophius Biosciences to Expand into T Cell-Based Testing Market". Neuried & Regensburg. 2021-03-08
Eli Lilly and Company. (3/8/21). "Press Release: Lilly and Biolojic Design Announce Research Collaboration to Discover and Develop Antibody Therapies for Diabetes". Indianapolis, IN & Tel Aviv. 2021-03-08
Excelya S.A.S.. (3/8/21). "Press Release: Nathalie Doize Appointed Director of Operations & Rudolph Rosenberg Appointed Chief Financial Officer". Boulogne-Billancourt. 2021-03-08
Pathios Therapeutics Ltd.. (3/8/21). "Press Release: Pathios Therapeutics Boosted by Award of Significant Innovate UK Funding". Oxford. 2021-03-08
Exscientia Ltd.. (3/4/21). "Press Release: Exscientia Completes $100 Million Series C Financing Round with BlackRock Funds". 2021-03-04
Autifony Therapeutics Ltd.. (3/4/21). "Press Release: Autifony Therapeutics, Boehringer Ingelheim to Collaborate On Novel Ion Channel Target with Potential in Multiple Disease Areas Related to Lysosomal Storage Disorders". Stevenage. 2021-03-04
Atai Life Sciences AG. (3/3/21). "Press Release: Atai Life Sciences Announces the Closing of Its $157 Million Series D Financing Round". New York, NY. 2021-03-03
LGC. (3/3/21). "Press Release: LGC Acquires Paragon Scientific, Strengthening Its Position in Reference Materials". London. 2021-03-03
Sofinnova Partners. (3/3/21). "Press Release: Sofinnova Partners Closes €445M ($540M) Oversubscribed Late-stage Healthcare Crossover Fund". Paris. 2021-03-03
ERS Genomics Ltd.. (3/3/21). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to Otsuka Pharmaceutical". Dublin. 2021-03-03
CVasThera. (3/3/21). "Press Release: CVasThera Secures €1.3 Million in First Funding Round". Toulouse. 2021-03-03
Dotmatics Ltd.. (3/3/21). "Press Release: Dotmatics Announces Licensing Agreement for Informatics Software with Compugen". Bishop’s Stortford. 2021-03-03
TrakCel Ltd.. (3/3/21). "Press Release: TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round". Cardiff. 2021-03-03
Oxford Genetics Ltd.. (3/2/21). "Press Release: WuXi AppTec Completes Acquisition of Oxgene to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers". Philadeliphia, PA & Oxford. 2021-03-02
Shorla Pharma Ltd.. (3/2/21). "Press Release: Shorla Pharma Announces U.S. Industry Veteran Nicholas Holsman as Chief Commercial Officer". Clonmel. 2021-03-02
ActiTrexx GmbH. (3/2/21). "Press Release: Newly Founded Biotech Company ActiTrexx Receives Funding of € 3.5 Million to Develop Cell Therapy against Transplant Rejection". Mainz. 2021-03-02
Argobio S.A.S.. (3/2/21). "Press Release: Argobio Announces Its Launch with 50 M€ to Create and Develop Pioneering Biotech Spinouts with the Support of Bpifrance, Kurma Partners, Angelini Pharma, Evotec, and the Institut Pasteur". Paris. 2021-03-02
Osborne Clarke. (3/2/21). "Press Release: Osborne Clarke Advises Oxular on Its £27M Financing". 2021-03-02
Molecular Health GmbH. (3/2/21). "Press Release: Molecular Health and Falco Biosystems Team Up to Provide Genetic Analysis Services Using MH Guide/BRCA and MH Guide/Mendel". Heidelberg. 2021-03-02
Royal Philips. (3/2/21). "Press Release: Shez Partovi to Succeed Jeroen Tas as Philips’ Chief Innovation & Strategy Officer". Amsterdam. 2021-03-02
Congenica Ltd.. (3/1/21). "Press Release: Congenica Appoints Kamraan Shariff as Chief Business Development Officer". Cambridge. 2021-03-01
ERS Genomics Ltd.. (3/1/21). "Press Release: ERS Genomics Expands Team With Appointment of Jon Kratochvil as VP Business Development". Dublin. 2021-03-01
Oxular Ltd.. (3/1/21). "Press Release: Oxular Raises $37 Million". Oxford. 2021-03-01
Cellink AB. (3/1/21). "Press Release: Cellink Completes the Acquisition of Ginolis Oy". 2021-03-01
Achilles Therapeutics plc. (3/1/21). "Press Release: Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States". London. 2021-03-01
Leukocare AG. (3/1/21). "Press Release: Leukocare and Malvern Collaborate on Stabilization and Formulation Development of COVID-19 Vaccines". Martinsried & Malvern. 2021-03-01
Chemieanlagenbau Chemnitz GmbH. (3/1/21). "Press Release: CAC Builds Biofuel Plant for OMV in Schwechat (A)". Chemnitz. 2021-03-01
EG 427. (3/1/21). "Press Release: EG 427 Announces €12 Million Series A Financing to Advance Its HSV-1 based Gene Therapy David Lamond and Stephane Boissel join the company’s board of Directors". Paris. 2021-03-01
Gyroscope Therapeutics Ltd.. (3/1/21). "Press Release: Gyroscope Therapeutics Appoints Jessica Stitt as Chief Financial Officer". London. 2021-03-01
Hologic, Inc.. (3/1/21). "Press Release: Hologic Acquires European Molecular Diagnostic Company Diagenode for Approximately $159 Million". Marlborough, MA. 2021-03-01
Nabriva Therapeutics plc. (2/26/21). "Press Release: Nabriva Therapeutics Appoints Daniel Dolan as Chief Financial Officer". Dublin & King of Prussia, PA. 2021-02-26
Roivant Sciences GmbH. (2/26/21). "Press Release: Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics". New York, NY, Boston, MA & Basel. 2021-02-26
Oncopeptides AB. (2/26/21). "Press Release: FDA Approves Oncopeptides' Pepaxto (melphalan flufenamide) for Patients with Relapsed or Refractory Multiple Myeloma". Stockholm. 2021-02-26
Celonic AG. (2/25/21). "Press Release: Celonic to Boost its Cell & Gene Therapy Production with Facility in the Upcoming Life Science Park Rheintal in Stein, Switzerland". Basel. 2021-02-25
Osborne Clarke. (2/25/21). "Press Release: Osborne Clarke Advised Delphi Genetics on Its Acquisition by Catalent". 2021-02-25
Bruker Corporation. (2/25/21). "Press Release: New Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurements and Deep Learning for 4D Proteomics". Munich. 2021-02-25
Coulter Partners. (2/25/21). "Press Release: Coulter Partners Announces New Appointments in London, the US and Germany". 2021-02-25
10x Genomics Inc.. (2/24/21). "Press Release: 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event. Acquires Tetramer Shop, Reveals Details on Upcoming Products". Pleasanton, CA. 2021-02-24
Orna Therapeutics. (2/24/21). "Press Release: Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies". Cambridge, MA. 2021-02-24
Vividion Therapeutics, Inc.. (2/24/21). "Press Release: Vividion Announces $135 Million Series C Financing to Fuel Broad Pipeline of Precision Oncology and Immunology Programs". San Diego, CA. 2021-02-24
Enamine Ltd.. (2/24/21). "Press Release: Enamine Extend Collaboration with Prominent Swiss Biotech". Kyiv. 2021-02-24
Aptum Biologics Ltd.. (2/24/21). "Press Release: New Features of EpiQuest Suite Software (v4)". Southampton. 2021-02-24
Newcells Biotech Ltd.. (2/23/21). "Press Release: Newcells Biotech Secures Over £5m for 3D Tissue Models". 2021-02-23
Catalent. (2/23/21). "Press Release: Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities". Somerset, NJ & Gosselies. 2021-02-23
Mosa Meat B.V.. (2/23/21). "Press Release: Mosa Meat Completes $85m Series B Investment Round". Maastricht. 2021-02-23
Bruker Corporation. (2/22/21). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA. 2021-02-22
Minaris Regnerative Medicine GmbH. (2/22/21). "Press Release: MaxiVAX and Minaris Regenerative Medicine Enter into a Manufacturing Partnership for MVX-ONCO-2 Cancer Immunotherapy". Geneva & Munich. 2021-02-22
Teon Therapeutics. (2/22/21). "Press Release: Teon Therapeutics Completes $30 Million Series A Financing". San Francisco, CA. 2021-02-22
Resolve Biosciences GmbH. (2/22/21). "Press Release: Resolve Biosciences Announces Initial Results from Early Access Collaborations with Scientists Leading the Next Generation of Subcellular Spatial Analysis". Monheim am Rhein. 2021-02-22
Novo Holdings A/S. (2/22/21). "Press Release: Novo Holdings to Acquire Altasciences". Copenhagen. 2021-02-22
Immunocore Holdings plc. (2/19/21). "Press Release: Immunocore’s Tebentafusp Granted Breakthrough Therapy Designation for Unresectable or Metastatic Uveal Melanoma from FDA". Oxfordshire, Conshohocken, PA & Rockville, MD. 2021-02-19
Evox Therapeutics Ltd.. (2/18/21). "Press Release: Evox Therapeutics Completes £69.2 Million Series C Financing". 2021-02-18
Charles River Laboratories International, Inc.. (2/17/21). "Press Release: Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development". Wilmington, MA. 2021-02-17
Almirall S.A.. (2/17/21). "Press Release: Almirall and MC2 Therapeutics Enter a License, Collaboration and Commercialization Agreement for European Rights to Wynzora Cream for Treatment of Plaque Psoriasis". Barcelona & Copenhagen. 2021-02-17
Hygiena, LLC. (2/16/21). "Press Release: EW Group Announces the Acquisition of Hygiena from Warburg Pincus to Form a Leading Food Safety, Veterinary and Environmental Diagnostic Solutions Company". Visbek & Camarillo, CA. 2021-02-16
InteRNA Technologies B.V.. (2/16/21). "Press Release: InteRNA Technologies Announces Dosing of First Patient in First-in-Human Trial of microRNA Drug Candidate INT-1B3 in Patients with Advanced Solid Tumors". Utrecht. 2021-02-16
Immunocore Holdings plc. (2/16/21). "Press Release: Immunocore Announces Key Appointments to Management and Board". Oxfordshire & Conshohocken, PA. 2021-02-16
Cellectis S.A.. (2/16/21). "Press Release: Cytovia Therapeutics and Cellectis Partner to Develop TALEN Gene-Edited iPSC-Derived Natural Killer Cells". Cambridge, MA & New York, NY. 2021-02-16
Biomunex Pharmaceuticals SASU. (2/16/21). "Press Release: Biomunex Pharmaceuticals Signs Strategic License and Co-Development Agreement with Onward Therapeutics for Proprietary Bispecific Antibody Program". Paris & Cambridge, MA. 2021-02-16
ERS Genomics Ltd.. (2/16/21). "Press Release: ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement". Dublin & Barcelona. 2021-02-16
Evaxion Biotech A/S. (2/16/21). "Press Release: Evaxion Biotech Opens New Office and Laboratories to Support Future Growth". Copenhagen. 2021-02-16
Bruker Corporation. (2/16/21). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2020 Financial Results". Billerica, MA. 2021-02-16
Centessa Pharmaceuticals Ltd.. (2/16/21). "Press Release: Centessa Pharmaceuticals Launches with $250 Million Series A Financing and Unveils a New Kind of Pharmaceutical R&D Model". Cambridge, MA & London. 2021-02-16
Discovery Park Ltd.. (2/15/21). "Press Release: Fast Growing Food Safety Testing Firm Curtis Analytics Relocates to Discovery Park". Sandwich, Kent. 2021-02-15
Cellink AB. (2/15/21). "Press Release: Cellink Has Entered into an Agreement to Acquire the Advanced Robotics and Diagnostics Automation Company Ginolis". 2021-02-15
CureVac N.V.. (2/12/21). "Press Release: CureVac Initiates Rolling Submission with European Medicines Agency for COVID-19 Vaccine Candidate, CVnCoV". Tübingen & Boston, MA. 2021-02-12
Quell Therapeutics Ltd.. (2/11/21). "Press Release: Quell Therapeutics Expands Series A Financing to $84 Million". London. 2021-02-11
MedinCell S.A.. (2/11/21). "Press Release: Tremendous Success for MedinCell’s €30 Million Capital Increase for Qualified Investors". Montpellier. 2021-02-11
Novartis AG. (2/11/21). "Press Release: Sandoz Announces Agreement to Acquire GSK’s Cephalosporin Antibiotics Business, Reinforcing Its Leading Global Position in Antibiotics". Basel. 2021-02-11
Immunai. (2/11/21). "Press Release: Immunai Raises $60M to Reprogram Immunity". New York, NY. 2021-02-11
Evonik Industries AG. (2/11/21). "Press Release: Evonik Strengthens Strategic Partnership with BioNTech on COVID-19 Vaccine". Essen. 2021-02-11
Rentschler Biopharma SE. (2/11/21). "Press Release: Rentschler Biopharma to Build New Cell and Gene Therapy Capabilities in the UK". London & Laupheim. 2021-02-11
EnginZyme AB. (2/11/21). "Press Release: EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden". Stockholm. 2021-02-11
Sophia Genetics S.A.. (2/11/21). "Press Release: Sophia Genetics Appoints Ross Muken as Chief Financial Officer". Boston, MA & Lausanne. 2021-02-11
Rentschler Biopharma SE. (2/11/21). "Press Release: Rentschler Biopharma Establishes Center of Excellence for Cell and Gene Therapy in the UK". Laupheim & Stevenage. 2021-02-11
Exscientia Ltd.. (2/11/21). "Press Release: Exscientia and the University of Oxford Announce Partnership to Develop Treatments for Alzheimer’s Disease". Oxford. 2021-02-11
SpyBiotech Ltd.. (2/10/21). "Press Release: SpyBiotech Raises $32.5M in Series A funding and Appoints Lutz B. Giebel as Chairman". Oxford. 2021-02-10
Forbion Capital Partners. (2/10/21). "Press Release: Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies". Amsterdam. 2021-02-10
Evaxion Biotech A/S. (2/10/21). "Press Release: Evaxion Biotech Closes Its U.S. Initial Public Offering of American Depositary Shares". Copenhagen. 2021-02-10
Galapagos N.V.. (2/10/21). "Press Release: Galapagos and Gilead Discontinue ISABELA Phase 3 Trials in IPF". Foster City, CA & Mechelen. 2021-02-10
Généthon. (2/10/21). "Press Release: Genethon and WhiteLab Genomics Join Forces to Enhance Gene Therapy through Artificial Intelligence". 2021-02-10
Immunocore Holdings plc. (2/9/21). "Press Release: Immunocore Announces Closing of $312.1 Million Aggregate Financing, Consisting of $297.1 Million Initial Public Offering, Full Exercise of Option to Purchase Additional ADSs and $15.0 Million Concurrent 2021-02-09
Exscientia Ltd.. (2/9/21). "Press Release: Exscientia Appoints Leading Financier Elizabeth Crain to the Board of Directors". Oxford. 2021-02-09
Evotec SE. (2/9/21). "Press Release: Evotec and Related Sciences Enter Integrated Drug Discovery and Development Partnership". Hamburg. 2021-02-09
Pan Cancer T B.V.. (2/8/21). "Press Release: Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center". 2021-02-08
CorWave S.A.. (2/8/21). "Press Release: CorWave Joins the French Tech 120 Index, a Community That Brings Together the Top French Tech Scale-up Companies". Clichy. 2021-02-08
InfanDx AG. (2/4/21). "Press Release: Neonatal Diagnostics Company InfanDx Appoints Achim Plum as CEO". Cologne. 2021-02-04
Secarna Pharmaceuticals GmbH & Co. KG. (2/4/21). "Press Release: Secarna Pharmaceuticals Appoints Alexander Gebauer, MD, PhD as CEO and Managing Director". Munich/Martinsried. 2021-02-04
Evaxion Biotech A/S. (2/4/21). "Press Release: Evaxion Biotech Announces Pricing of Initial Public Offering". Copenhagen. 2021-02-04
PepGen Ltd.. (2/4/21). "Press Release: PepGen Announces Appointment of James McArthur, Ph.D., as President and Chief Executive Officer". Boston, MA & Oxford. 2021-02-04
V-Bio Ventures. (2/4/21). "Press Release: First Closing of V-Bio Fund 2 Is Announced at EUR 78 Million". Ghent. 2021-02-04
Tecan Group Ltd.. (2/4/21). "Press Release: Tecan and UgenTec Partner to Offer Sample-to-result Solutions for qPCR". Männedorf. 2021-02-04
GlaxoSmithKline plc. (2/3/21). "Press Release: GSK and CureVac to Develop Next Generation mRNA COVID-19 Vaccines". London, Tübingen & Boston, MA. 2021-02-03
Wacker Chemie AG. (2/3/21). "Press Release: Wacker Strengthens Biologics Business by Acquiring US-based Plasmid DNA Manufacturer Genopis". Munich & San Diego, CA. 2021-02-03
Scienion AG. (2/3/21). "Press Release: Scienion Continues to Grow and Will Build New Headquarters in Berlin Adlershof". Berlin. 2021-02-03
Abingworth LLP. (2/3/21). "Press Release: Abingworth Raises $465m for New Life Sciences Fund Abingworth Bioventures 8". London. 2021-02-03
Almirall S.A.. (2/3/21). "Press Release: Almirall Announces Gianfranco Nazzi as New CEO". 2021-02-03
Jazz Pharmaceuticals plc. (2/3/21). "Press Release: Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader". Dublin & London. 2021-02-03
next pagenext page 1 2 3 ... 82 83 84  next pagenext page


Picture [iito] Plain Stupid Simple 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [iito] Back into Ad 650x80px

» top